This is the authors' abstract. We don't add key points for this paper.
Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Efird et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: